Get started
JetEquities

Abiomed Announces Increases Full Year Guidance!!!

Long
JetEquities  
NASDAQ:ABMD   None
Beyond Technical Analysis
1
0
beyondta
2019-01-07 07:00:00
Abiomed Announces Preliminary Q3 FY 2019 Revenue of $201 Million, Up 30% Over Prior Year and Increases Full Year Guidance
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.